Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Clinical trial NCT05739123 · RECRUITING

Trial details

NCT number: NCT05739123
Sponsor: Sumitomo Pharma Switzerland GmbH
Status: RECRUITING
Study type: OBSERVATIONAL

Pregnancy Related Pregnancy Complications Pregnancy, High Risk

Start date: 2023-05-08
Primary completion: 2033-05-01
Enrollment: 728

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.